REVIEW
Add like
Add dislike
Add to saved papers

New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activation.

In addition to its growth regulating properties, new evidence reviewed here by Diane Haddock Russell demonstrates that prolactin has important immunoregulatory properties. In immune-compromised dwarf mice, prolactin restores immunocompetence. Human lymphocytes have prolactin receptors and mitogen-stimulated lymphocytes make and secrete a prolactin-like activity. Prolactin can stimulate the activation of nuclear protein kinase C in spleen and liver isolated nuclear preparations. This activation is blocked by prolactin receptor monoclonal antibody, suggesting that there is a receptor-mediated activation process in the nucleus. The discovery of the ability of prolactin and growth factors to activate nuclear protein kinase C may constitute a breakthrough in our understanding of how these hormones regulate trophic responses.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app